Liothyronine Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 87063-082
  • Package NDC 87063-082-01
  • Package NDC 87063-082-30
  • Package NDC 87063-082-60
  • Package NDC 87063-082-90
  • Application number ANDA200295
  • SPL ID 4a5e9691-7284-6bcd-e063-6294a90aadfc
  • SPL set ID 26cf6872-f4d4-41dd-8957-a000f13efbb3
  • UNII GCA9VV7D2N
  • RxCUI 903456
  • RxCUI 903697
  • RxCUI 903703

What the source publishes

Labeler
ASCLEMED USA INC.
Active ingredients
Liothyronine Sodium
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:87063-082_4a5e9691-7284-6bcd-e063-6294a90aadfc
{
  "name": "Liothyronine Sodium",
  "splId": "4a5e9691-7284-6bcd-e063-6294a90aadfc",
  "labels": [
    {
      "setId": "26cf6872-f4d4-41dd-8957-a000f13efbb3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=26cf6872-f4d4-41dd-8957-a000f13efbb3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=26cf6872-f4d4-41dd-8957-a000f13efbb3"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "ASCLEMED USA INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (87063-082-01)",
      "package_ndc": "87063-082-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260209"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (87063-082-30)",
      "package_ndc": "87063-082-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260209"
    },
    {
      "sample": false,
      "description": "60 TABLET in 1 BOTTLE (87063-082-60)",
      "package_ndc": "87063-082-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260209"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (87063-082-90)",
      "package_ndc": "87063-082-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260209"
    }
  ],
  "productId": "87063-082_4a5e9691-7284-6bcd-e063-6294a90aadfc",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "87063-082",
  "deaSchedule": null,
  "genericName": "Liothyronine Sodium",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LIOTHYRONINE SODIUM",
      "strength": "50 ug/1"
    }
  ],
  "applicationNumber": "ANDA200295",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20121203",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "GCA9VV7D2N"
    ],
    "rxcui": [
      "903456",
      "903697",
      "903703"
    ],
    "spl_set_id": [
      "26cf6872-f4d4-41dd-8957-a000f13efbb3"
    ],
    "manufacturer_name": [
      "ASCLEMED USA INC."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:87063-082_4a5e9691-7284-6bcd-e063-6294a90aadfc"